InvestorsHub Logo

skitahoe

03/06/22 7:53 PM

#43243 RE: Scott999 #43242

We're speaking of different trials, I'm talking about the Phase 3 referenced in this release:

https://ih.advfn.com/stock-market/NASDAQ/pluristem-therapeutics-PSTI/stock-news/87435368/pluristem-ceo-issues-shareholder-update

If data in that trial isn't worthy of approval perhaps we wait for the meat, but I believe the Phase 3 will demonstrate improvements in circulation that make it worthy of approval.

Gary